Insider Selling: Dolby Laboratories (NYSE:DLB) CEO Sells 34,367 Shares of Stock

Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman sold 34,367 shares of Dolby Laboratories stock in a transaction dated Tuesday, December 9th. The shares were sold at an average price of $67.08, for a total value of $2,305,338.36. Following the completion of the sale, the chief executive officer owned 98,377 shares of the company’s stock, valued at $6,599,129.16. The trade was a 25.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Dolby Laboratories Stock Performance

Dolby Laboratories stock traded down $0.61 during midday trading on Thursday, hitting $67.68. 411,147 shares of the company’s stock were exchanged, compared to its average volume of 469,529. The company has a market cap of $6.46 billion, a PE ratio of 25.73 and a beta of 0.89. The firm has a 50-day moving average of $67.30 and a two-hundred day moving average of $71.52. Dolby Laboratories has a 12 month low of $64.02 and a 12 month high of $89.66.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. The firm had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The company’s quarterly revenue was up .7% on a year-over-year basis. During the same period last year, the firm earned $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, equities analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were given a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio is presently 54.75%.

Analyst Upgrades and Downgrades

DLB has been the topic of a number of recent research reports. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Tigress Financial increased their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Robert W. Baird started coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 price objective on the stock. Rosenblatt Securities reduced their price objective on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Finally, Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and an average price target of $92.00.

Hedge Funds Weigh In On Dolby Laboratories

Hedge funds have recently modified their holdings of the stock. Norges Bank purchased a new position in shares of Dolby Laboratories in the 2nd quarter valued at approximately $55,030,000. AQR Capital Management LLC increased its stake in Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after purchasing an additional 592,282 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Dolby Laboratories by 7.1% in the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after buying an additional 502,110 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Dolby Laboratories by 241,160.1% in the first quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker’s stock worth $36,975,000 after buying an additional 429,265 shares during the last quarter. Finally, First Trust Advisors LP lifted its stake in shares of Dolby Laboratories by 35.2% during the second quarter. First Trust Advisors LP now owns 1,237,443 shares of the electronics maker’s stock worth $91,893,000 after buying an additional 322,063 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.